Video

How Can Innovative Nanoparticle Engineering Make The Difference For Alzheimer's?

Source: Nanoform

Alzheimer's is the most common cause of dementia, a general term for memory loss and other cognitive abilities serious enough to interfere with daily life. Alzheimer's disease accounts for 60-80% of dementia cases.

We are thinking about how we at Nanoform can facilitate the next wave of novel medicines for this debilitating disease. Access the video to hear our Commercial Insights Officer, Jamie Unwin, discuss the power of Nanoform's innovative nanoparticle engineering technology and AI-based digital twin.

access the Video!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Drug Discovery Online? Subscribe today.

Subscribe to Drug Discovery Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Drug Discovery Online